SCHEMBL2492907

SCHEMBL2492907

NCCOC(c1ccccc1)(c1ccccc1)c1ccccc1F

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 8/20 0.70
KCNN4 O15554 5/20 0.44
KCNE1 P15382 1/20 0.40
KCNQ1 P51787 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
TAAR1 Q96RJ0 1/20 0.37
ALOX15 P16050 2/20 0.35
TSHR P16473 2/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
TRPM2 O94759 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
THRB P10828 1/20 0.34
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2489578 0.90 KIF11 (0.56) KIF11KCNN4KCNE1KCNQ1ALOX15
SCHEMBL2492372 0.89 KIF11 (0.57) KIF11KCNN4KCNE1KCNQ1SMN1; SMN2
SCHEMBL2491322 0.85 KIF11 (0.49) KIF11KCNN4KCNE1KCNQ1ALOX15
SCHEMBL2492363 0.83 KIF11 (1.00) KIF11KCNN4SMN1; SMN2TAAR1ALOX15
SCHEMBL2492412 0.82 KIF11 (0.46) KIF11KCNN4KCNE1KCNQ1ALOX15
SCHEMBL2493486 0.81 KIF11 (0.68) KIF11SMN1; SMN2TAAR1
SCHEMBL2489422 0.79 KIF11 (0.64) KIF11SMN1; SMN2TAAR1KDM4EALDH1A1
SCHEMBL2490788 0.79 KIF11 (0.44) KIF11KCNN4TAAR1TDP1
SCHEMBL12199498 0.74 KIF11 (0.79) KIF11SMN1; SMN2
SCHEMBL13671082 0.73 KIF11 (0.78) KIF11SMN1; SMN2TAAR1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH KIF11 4556/4885KCNN4 2642/4885KCNE1 2767/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 KIF11 4605/4885KCNN4 2867/4885KCNE1 2922/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R KIF11 4611/4885KCNN4 2809/4885KCNE1 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.